First Time Loading...

Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 15.94 USD 1.85% Market Closed
Updated: May 13, 2024

Wall Street
Price Targets

CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc

Wall Street analysts forecast CPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPRX is 27.25 USD with a low forecast of 22.22 USD and a high forecast of 35.7 USD.

Lowest
Price Target
22.22 USD
39% Upside
Average
Price Target
27.25 USD
71% Upside
Highest
Price Target
35.7 USD
124% Upside
Catalyst Pharmaceuticals Inc Competitors:
Price Targets
688363
Bloomage Biotechnology Corp Ltd
17% Upside
MRKR
Marker Therapeutics Inc
190% Upside
300676
BGI Genomics Co Ltd
141% Upside
ZEAL
Zealand Pharma A/S
26% Upside
086890
Isu Abxis Co Ltd
120% Upside
AFMD
Affimed NV
344% Upside
CSL
CSL Ltd
11% Upside
MOR
MorphoSys AG
15% Downside

Revenue
Forecast

Revenue Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 3 years is 43%.

N/A
Past Growth
43%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPRX's stock price target?
Price Target
27.25 USD

According to Wall Street analysts, the average 1-year price target for CPRX is 27.25 USD with a low forecast of 22.22 USD and a high forecast of 35.7 USD.

What is Catalyst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
17%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 3 years is 17%.

What is Catalyst Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
43%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 3 years is 43%.

What is Catalyst Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
40%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 3 years is 40%.